Advertisement
Screener

IQVIA HOLDINGS INC. (IQV) OCI, before Reclassifications, Net of Tax, Attributable to Parent

IQVIA HOLDINGS INC. OCI, before Reclassifications, Net of Tax, Attributable to Parent

IQVIA HOLDINGS INC. (IQV) reported OCI, before Reclassifications, Net of Tax, Attributable to Parent of -$32.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent · last filed 2026-05-05

  • IQVIA HOLDINGS INC. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2026-03-31 was -$32.00M, a 154.24% decline year-over-year.
  • IQVIA HOLDINGS INC. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2025-12-31 was -$11.00M.
  • IQVIA HOLDINGS INC. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2025-09-30 was -$43.00M, a 132.82% decline year-over-year.
  • IQVIA HOLDINGS INC. oci, before reclassifications, net of tax, attributable to parent for the quarter ending 2025-06-30 was $98.00M.
  • IQVIA HOLDINGS INC. oci, before reclassifications, net of tax, attributable to parent for fiscal 2025 was $103.00M.
  • IQVIA HOLDINGS INC. oci, before reclassifications, net of tax, attributable to parent for fiscal 2024 was -$140.00M.
  • IQVIA HOLDINGS INC. oci, before reclassifications, net of tax, attributable to parent for fiscal 2023 was -$89.00M.
  • IQVIA HOLDINGS INC. oci, before reclassifications, net of tax, attributable to parent for fiscal 2022 was -$331.00M.
Period endOCI, before Reclassifications, Net of Tax, Attributable to Parent 3 monthOCI, before Reclassifications, Net of Tax, Attributable to Parent 6 monthOCI, before Reclassifications, Net of Tax, Attributable to Parent 9 monthOCI, before Reclassifications, Net of Tax, Attributable to Parent 12 monthOCI, before Reclassifications, Net of Tax, Attributable to Parent 12 month as first filed
2026-03-31-$32.00M
10-Q · filed 2026-05-05
-$43.00M
derived: sum of 2 quarters · filed 2026-05-05
-$86.00M
derived: sum of 3 quarters · filed 2026-05-05
$12.00M
derived: sum of 4 quarters · filed 2026-05-05
2025-12-31-$11.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
-$54.00M
derived: sum of 2 quarters · filed 2026-02-17
$44.00M
derived: sum of 3 quarters · filed 2026-02-17
$103.00M
10-K · filed 2026-02-17
2025-09-30-$43.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$55.00M
derived: sum of 2 quarters · filed 2025-10-28
$114.00M
10-Q · filed 2025-10-28
-$95.00M
derived: sum of 4 quarters · filed 2026-02-17
2025-06-30$98.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22
$157.00M
10-Q · filed 2025-07-22
-$52.00M
derived: sum of 3 quarters · filed 2026-02-17
$79.00M
derived: sum of 4 quarters · filed 2026-02-17
2025-03-31$59.00M
10-Q · filed 2025-05-06
-$150.00M
derived: sum of 2 quarters · filed 2026-02-17
-$19.00M
derived: sum of 3 quarters · filed 2026-02-17
-$46.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-12-31-$209.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
-$78.00M
derived: sum of 2 quarters · filed 2026-02-17
-$105.00M
derived: sum of 3 quarters · filed 2026-02-17
-$140.00M
10-K · filed 2026-02-17
2024-09-30$131.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$104.00M
derived: sum of 2 quarters · filed 2024-10-31
$69.00M
10-Q · filed 2024-10-31
$115.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-06-30-$27.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22
-$62.00M
10-Q · filed 2024-07-22
-$16.00M
derived: sum of 3 quarters · filed 2026-02-17
-$150.00M
derived: sum of 4 quarters · filed 2026-02-17
2024-03-31-$35.00M
10-Q · filed 2024-05-02
$11.00M
derived: sum of 2 quarters · filed 2026-02-17
-$123.00M
derived: sum of 3 quarters · filed 2026-02-17
-$145.00M
derived: sum of 4 quarters · filed 2026-02-17
2023-12-31$46.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
-$88.00M
derived: sum of 2 quarters · filed 2026-02-17
-$110.00M
derived: sum of 3 quarters · filed 2026-02-17
-$89.00M
10-K · filed 2026-02-17
2023-09-30-$134.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
-$156.00M
derived: sum of 2 quarters · filed 2023-11-01
-$135.00M
10-Q · filed 2023-11-01
$40.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30-$22.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
-$1.00M
10-Q · filed 2023-08-01
$174.00M
derived: sum of 3 quarters · filed 2025-02-13
-$28.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$21.00M
10-Q · filed 2023-04-28
$196.00M
derived: sum of 2 quarters · filed 2025-02-13
-$6.00M
derived: sum of 3 quarters · filed 2025-02-13
-$298.00M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$175.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
-$27.00M
derived: sum of 2 quarters · filed 2025-02-13
-$319.00M
derived: sum of 3 quarters · filed 2025-02-13
-$331.00M
10-K · filed 2025-02-13
2022-09-30-$202.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
-$494.00M
derived: sum of 2 quarters · filed 2022-10-27
-$506.00M
10-Q · filed 2022-10-27
-$472.00M
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30-$292.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22
-$304.00M
10-Q · filed 2022-07-22
-$270.00M
derived: sum of 3 quarters · filed 2024-02-15
-$391.00M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31-$12.00M
10-Q · filed 2022-04-28
$22.00M
derived: sum of 2 quarters · filed 2024-02-15
-$99.00M
derived: sum of 3 quarters · filed 2024-02-15
-$43.00M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31$34.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
-$87.00M
derived: sum of 2 quarters · filed 2024-02-15
-$31.00M
derived: sum of 3 quarters · filed 2024-02-15
-$203.00M
10-K · filed 2024-02-15
2021-09-30-$121.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22
-$65.00M
derived: sum of 2 quarters · filed 2021-10-22
-$237.00M
10-Q · filed 2021-10-22
-$129.00M
derived: sum of 4 quarters · filed 2023-02-15
2021-06-30$56.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
-$116.00M
10-Q · filed 2021-07-28
-$8.00M
derived: sum of 3 quarters · filed 2023-02-15
$117.00M
derived: sum of 4 quarters · filed 2023-02-15
2021-03-31-$172.00M
10-Q · filed 2021-04-23
-$64.00M
derived: sum of 2 quarters · filed 2023-02-15
$61.00M
derived: sum of 3 quarters · filed 2023-02-15
$114.00M
derived: sum of 4 quarters · filed 2023-02-15
2020-12-31$108.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15
$233.00M
derived: sum of 2 quarters · filed 2023-02-15
$286.00M
derived: sum of 3 quarters · filed 2023-02-15
$96.00M
10-K · filed 2023-02-15
2020-09-30$125.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22
$178.00M
derived: sum of 2 quarters · filed 2020-10-22
-$12.00M
10-Q · filed 2020-10-22
$53.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30$53.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23
-$137.00M
10-Q · filed 2020-07-23
-$72.00M
derived: sum of 3 quarters · filed 2022-02-16
-$236.00M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31-$190.00M
10-Q · filed 2020-04-30
-$125.00M
derived: sum of 2 quarters · filed 2022-02-16
-$289.00M
derived: sum of 3 quarters · filed 2022-02-16
-$239.00M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31$65.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
-$99.00M
derived: sum of 2 quarters · filed 2022-02-16
-$49.00M
derived: sum of 3 quarters · filed 2022-02-16
-$86.00M
10-K · filed 2022-02-16
2019-09-30-$164.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01
-$114.00M
derived: sum of 2 quarters · filed 2019-11-01
-$151.00M
10-Q · filed 2019-11-01
-$144.00M
derived: sum of 4 quarters · filed 2021-02-12
2019-06-30$50.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
$13.00M
10-Q · filed 2019-07-24
$20.00M
derived: sum of 3 quarters · filed 2021-02-12
-$96.00M
derived: sum of 4 quarters · filed 2021-02-12
2019-03-31-$37.00M
10-Q · filed 2019-05-02
-$30.00M
derived: sum of 2 quarters · filed 2021-02-12
-$146.00M
derived: sum of 3 quarters · filed 2021-02-12
-$503.00M
derived: sum of 4 quarters · filed 2021-02-12
2018-12-31$7.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12
-$109.00M
derived: sum of 2 quarters · filed 2021-02-12
-$466.00M
derived: sum of 3 quarters · filed 2021-02-12
-$262.00M
10-K · filed 2021-02-12
2018-09-30-$116.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25
-$473.00M
derived: sum of 2 quarters · filed 2018-10-25
-$269.00M
10-Q · filed 2018-10-25
-$147.00M
derived: sum of 4 quarters · filed 2020-02-18
2018-06-30-$357.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27
-$153.00M
10-Q · filed 2018-07-27
-$31.00M
derived: sum of 3 quarters · filed 2020-02-18
$125.00M
derived: sum of 4 quarters · filed 2020-02-18
2018-03-31$204.00M
10-Q · filed 2018-05-04
$326.00M
derived: sum of 2 quarters · filed 2020-02-18
$482.00M
derived: sum of 3 quarters · filed 2020-02-18
$693.00M
derived: sum of 4 quarters · filed 2020-02-18
2017-12-31$122.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18
$278.00M
derived: sum of 2 quarters · filed 2020-02-18
$489.00M
derived: sum of 3 quarters · filed 2020-02-18
$613.00M
10-K · filed 2020-02-18
$616.00M
10-K · filed 2018-02-16
2017-09-30$156.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27
$367.00M
derived: sum of 2 quarters · filed 2017-10-27
$491.00M
10-Q · filed 2017-10-27
$58.49M
derived: sum of 4 quarters · filed 2019-02-19
2017-06-30$211.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$335.00M
10-Q · filed 2017-08-04
-$97.51M
derived: sum of 3 quarters · filed 2019-02-19
2017-03-31$124.00M
10-Q · filed 2017-05-08
-$308.51M
derived: sum of 2 quarters · filed 2019-02-19
2016-12-31-$432.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19
-$476.00M
10-K · filed 2019-02-19
-$481.00M
10-K · filed 2018-02-16
2016-09-30-$43.49M
10-Q · filed 2016-11-03
2015-12-31-$65.00M
10-K · filed 2018-02-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
INCYTE CORP (INCY)United States$24.855B13.14
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B